MHR
DGX icon

Matthew Hamilton Rosenberg’s Quest Diagnostics DGX Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.6K Hold
110
– – ﹤0.01% 526
2026
Q2 		$23.3K Hold
110
– – ﹤0.01% 541
2026
Q1 		$21.6K Hold
110
– – ﹤0.01% 537
2025
Q4 		$19.1K Sell
110
-2
-2% -$364 ﹤0.01% 551
2025
Q3 		$21.3K Hold
112
– – ﹤0.01% 532
2025
Q2 		$20.1K Hold
112
– – ﹤0.01% 560
2025
Q1 		$18.9K Buy
112
+32
+40% +$5.26K ﹤0.01% 542
2024
Q4 		$12.1K Hold
80
– – ﹤0.01% 604
2024
Q3 		$12.4K Buy
80
+39
+95% +$5.82K ﹤0.01% 588
2024
Q2 		$5.62K Sell
41
-39
-49% -$5.34K ﹤0.01% 647
2024
Q1 		$10.8K Hold
80
– – ﹤0.01% 599
2023
Q4 		$11K Buy
80
+39
+95% +$5.13K ﹤0.01% 598
2023
Q3 		$5K Hold
41
– – ﹤0.01% 684
2023
Q2 		$5.76K Hold
41
– – ﹤0.01% 677
2023
Q1 		$5.8K Hold
41
– – ﹤0.01% 719
2022
Q4 		$6.41K Hold
41
– – ﹤0.01% 704
2022
Q3 		$5K Buy
+41
New +$5.4K ﹤0.01% 708

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Matthew Hamilton Rosenberg's DGX Position: Q3 2026 in Review

Matthew Hamilton Rosenberg held its Quest Diagnostics (DGX) position steady in Q3 2026 at 110 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Matthew Hamilton Rosenberg first reported a position in DGX in Q3 2022 and has held it in 17 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Matthew Hamilton Rosenberg held 110 shares of Quest Diagnostics worth $25.6K as of Q3 2026.
  • Matthew Hamilton Rosenberg left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #526 holding.
  • Matthew Hamilton Rosenberg first reported a position in Quest Diagnostics in Q3 2022 and has held it in 17 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.